
Imatinib enchances the sensitivity of gastrointestinal stromal tumors to topoisomerase II inhibitors
Author(s) -
S. V. Boichuk,
Aigul Galembikova,
Bulat R. Ramazanov,
A. Duensing
Publication year - 2015
Publication title -
uspehi molekulârnoj onkologii
Language(s) - English
Resource type - Journals
eISSN - 2413-3787
pISSN - 2313-805X
DOI - 10.17650/2313-805x.2015.2.1.76-81
Subject(s) - etoposide , topoisomerase , imatinib , cancer research , topoisomerase inhibitor , propidium iodide , biology , apoptosis , dna damage , microbiology and biotechnology , dna , chemotherapy , programmed cell death , biochemistry , genetics , myeloid leukemia